Quarterly report pursuant to Section 13 or 15(d)

Business, Presentation and Recent Accounting Pronouncements (Details)

v3.24.2.u1
Business, Presentation and Recent Accounting Pronouncements (Details)
1 Months Ended 3 Months Ended
Jun. 11, 2024
shares
Jan. 31, 2024
performance_obligation
Mar. 31, 2024
USD ($)
Jun. 30, 2024
USD ($)
shares
Jun. 10, 2024
shares
May 01, 2024
shares
Dec. 31, 2023
USD ($)
shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]              
Reverse stock split, conversion ratio 0.111111111111111            
Common stock, shares authorized (in shares) | shares 150,000,000     150,000,000   150,000,000 50,000,000
Common stock, shares, outstanding (in shares) | shares 2,970,545     2,970,545 26,735,116   856,182
Cash and cash equivalents       $ 6,575,394     $ 2,454,684
Short-term investments       21,242,671     0
Accumulated deficit       $ 135,745,294     $ 146,976,855
Number of performance obligations | performance_obligation   1          
Proceeds from collaborators     $ 16,000,000